Center on Health Equity & Access
Clinical
Health Care Cost
Health Care Delivery
Insurance
Policy
Technology
Value-Based Care

Biosimilars Cardiorenalmetabolic Dermatology Gastroenterology Hematology Hepatology Immunology Infectious Disease Mental Health Neurology Obesity Oncology Ophthalmology Pulmonology Rare Disease Respiratory Rheumatology Women's Health

Free In-Person Regional Events Focused on Oncology and Population Health

Biosimilars Center on Health Equity & Access Digital Health Formulary Gene Therapy Guidelines Health Care Administration Health Care Cost Health Care Delivery Insurance Policy Population Health Product Approvals and Launches Technology Value-Based Care

All Coverage Event Coverage Interviews News

AJMC Journals Anniversary Author Forms Authors Nominate a Rising Leader Submit a Manuscript

The American Society of Clinical Oncology Annual Meeting, 2014

home / publications / evidence-based-oncology / the-american-society-of-clinical-oncology-annual-meeting-2014

Achieving Value in Cancer Care-the Case of Low- and Middle-Income Countries

Ajay Aggarwal, MD;Richard Sullivan, MD, PhD

August 21st 2014

ArticleEvidence-Based Oncology

Commentary

The Global Perspective on Value in Cancer Care

Based on presentations by Elisabeth De Vries, MD, PhD;Richard Sullivan, MD, PhD;Lowell E. Schnipper, MD

August 21st 2014

ArticleEvidence-Based Oncology

Overdiagnosis and Overtreatment: The Cancer Paradigm

Based on presentations by Barbara L. Smith, MD, PhD;Rina S. Punglia, MD, MPH;Laura Esserman, MD, MBA,

August 21st 2014

ArticleEvidence-Based Oncology

Velcade: A Progress Report in Various Cancers

August 21st 2014

ArticleEvidence-Based Oncology

Impact of the Affordable Care Act on Cancer Care

Based on presentations by Rena M. Conti, PhD;Lawrence N. Shulman, MD;Blase N. Polite, MD, MPP

August 21st 2014

ArticleEvidence-Based Oncology

In Conversation With ASCO President Peter Paul Yu

August 21st 2014

ArticleEvidence-Based Oncology

Clinical Pathway Adherence and Barriers to Coverage

August 21st 2014

ArticleEvidence-Based Oncology

The Oncologist Defines Value of Care

Based on presentations by Reshma Jagsi, MD, DPhil;Daniel P. Sulmasy, MD, PhD;Beverly Moy, MD, MPH

August 21st 2014

ArticleEvidence-Based Oncology

Promising Results in Leukemia From a BCL-2 Inhibitor

August 20th 2014

ArticleEvidence-Based Oncology

Cancer Care in the United States: The Path Ahead

Surabhi Dangi-Garimella, PhD

August 20th 2014

ArticleEvidence-Based Oncology

The EGF Receptor (EGFR) Continues to Be a Promising Target in NSCLC

Based on presentations by Pasi A. Janne, MD, PhD;Lecia V. Sequist, MD, MPH;Gideon Michael Blumenthal, MD;Lawrence H. Schwartz, MD

August 20th 2014

ArticleEvidence-Based Oncology

Recent Content

Richard Nowak, MD, MS, Yale School of Medicine

52-Week MINT Data Confirm Inebilizumab Benefit in AChR+ gMG: Richard Nowak, MD, MS

medicine and money for ulcerative colitis | Image credit: gopixa - stock.adobe.com

Vedolizumab First Shows Clinical and Economic Advantage in Ulcerative Colitis

syringes and pharmaceuticals in development | Image credit: Napat - stock.adobe.com

US Pharmaceutical Pipeline Expands With Innovation and Competition

OUD-focused discharge plans were significantly more common in the START group vs the usual care group, and START patients were more likely to initiate or continue MOUD following discharge vs usual care. | VILevi - stock.adobe.com

Hospital-Based Addiction Consultation Addresses Gaps, Improves Treatment Rate

View More Recent Content

Editorial Boards

Do Not Sell My Information

Terms & Conditions

Contact Info

2 Commerce Drive
Cranbury, NJ 08512

© 2025 MJH Life Sciences
AJMC®
All rights reserved.